Ledger.Open graph →

SEC Form D · filed July 14, 2020

Kitov Pharma Ltd

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

TEL AVIV, L3

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Hadas Reuveni · Tel Aviv, L3Exec Gil Efron · Tel Aviv, L3Exec Eric Rowinsky · Tel Aviv, L3Director Ran Tzror · Tel Aviv, L3Director Revital Stern-Raff · Tel Aviv, L3Director Ido Agmon · Tel Aviv, L3Director Bertrand Liang · Tel Aviv, L3Exec Isaac Israel · Tel Aviv, L3Exec · Director Steven Steinberg · Tel Aviv, L3Director Michael Schickler · Tel Aviv, L3Exec Simcha Rock · Tel Aviv, L3Director Paul Young · Exeter, NHDirector Jay Bush · BOSTON, MADirector David Rottman · Santa Barbara, CAExec Stavros Koutsantonis · Exeter, NHExec Richard F. Lunsford · conshohocken, PADirector Kyle York · BOSTON, MAExec · Director Carl S. Pappo · New York, NYDirector Mark Mcgarry · BOSTON, MADirector ArrowMark CLO Equity Strategic Partners Fund GP, LLC · Denver, CODirector Curtis L. Scribner · Berkeley, CAExec Sanjai N. Bhonsle · Denver, COExec Jeffrey Grimberg · Seattle, WADirector Wendy W. Dicicco · Pittsburgh, PADirector Quinn Rotchford · Seattle, WADirector John K. Mastrototaro · Dania Beach, FLDirector Steven K. Seger · Dania Beach, FLExec · Director Scott Baker · Overland, KSDirector Scott Duba · Overland, KSExec Paul R. Gatzmeier · Golden, COExec Robert Aren · Deerfield, ILDirector Vicki Esralew · Deerfield, ILExec Phillip J. Keller · Minnetonka, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗